scholarly journals SAT0259 High plasma concentration of mycophenolate acid in early phase of induction therapy predicts good renal outcome in lupus nephritis class iii or iv

Author(s):  
T Kiyokawa ◽  
H Hanaoka ◽  
H Iida ◽  
K Ishimori ◽  
Y Takakuwa ◽  
...  
2019 ◽  
Vol 30 (3) ◽  
pp. 517-524
Author(s):  
Tomofumi Kiyokawa ◽  
Hironari Hanaoka ◽  
Harunobu Iida ◽  
Kana Ishimori ◽  
Yukiko Takakuwa ◽  
...  

1969 ◽  
Vol 21 (02) ◽  
pp. 320-324 ◽  
Author(s):  
K Seiler ◽  
F Duckert

SummaryA case of severe Marcoumar intoxication is described. Eleven hours after the intake a plasma concentration of 15.75 µg/ml was found which corresponds approximately to the 5-fold therapeutic concentration. Repeated administration of vitamin K1 made it possible to avoid extreme lowering of the activity of the clotting factors II, VII and X and to prevent bleeding. Side effects were not observed. The biologic half-life of Phenprocoumon has been found to be shortened at high plasma concentration (3.7 instead of 5.9 days). It is probable that in extreme concentration the drug is less strongly bound to the plasma proteins.


Author(s):  
Matthieu Halfon ◽  
Delphine Bachelet ◽  
Guillaume Hanouna ◽  
Barbara Dema ◽  
Christophe Pellefigues ◽  
...  

Abstract Background Basophils were recently shown to contribute to lupus nephritis (LN). This study assessed blood basophil activation markers (BAMs) for the diagnosis of LN severity and as pre-treatment prognostic markers of the response to treatment in patients with severe LN. Method The diagnostic study included all the patients of a monocentric prospective observational cohort built with consecutive patients diagnosed with LN on the basis of a renal biopsy. The prognostic study selected patients of this cohort according to the following inclusion criteria: ≥18 years old, Class III or IV A ± C ± Class V or pure Class V LN at the time of inclusion and treated with an induction treatment for LN. Clinical data and BAMs were obtained at the time of the kidney biopsy. LN remission status was recorded 12 months after induction therapy initiation. Associations between baseline data and histological severity of LN or LN remission were assessed using logistic regression. Results No significant association was found between BAMs and the histological severity of LN in 101 patients. Among the 83 patients included in the prognostic study, 64 reached renal remission. CD62L expression on blood basophils at baseline was independently negatively associated with remission at 12 months [odds ratio = 0.26, 95% confidence interval 0.08–0.82, P = 0.02 for quantitative CD62L expression >105 (geometric fluorescent intensity) gMFI]. CD62L <105 gMFI was associated with a probability of 0.87 of LN remission in the next 12 months after the start of induction therapy. Conclusion Pre-treatment CD62L expression on blood basophils could be a first predictive biomarker of renal response to induction therapy at 12 months in patients with severe LN.


2020 ◽  
Vol 80 ◽  
pp. 52-55 ◽  
Author(s):  
Stéphane Jaisson ◽  
Aurore Desmons ◽  
Antoine Braconnier ◽  
Alain Wynckel ◽  
Philippe Rieu ◽  
...  

2020 ◽  
Author(s):  
Maxime Nguyen ◽  
Abderrahmane Bourredjem ◽  
Lionel Piroth ◽  
Bélaïd Bouhemad ◽  
Antoine Jalil ◽  
...  

Lupus ◽  
2017 ◽  
Vol 27 (3) ◽  
pp. 461-467 ◽  
Author(s):  
E S Park ◽  
S S Ahn ◽  
S M Jung ◽  
J J Song ◽  
Y-B Park ◽  
...  

We investigated renal outcome of kidney-transplantation in 19 Korean recipients with biopsy-proven lupus nephritis and compared it with 18 Korean age- and gender-matched recipients without lupus nephritis who were diagnosed with end-stage renal disease caused by renal diseases other than lupus nephritis in a single centre. We reviewed histological findings of kidneys and calculated cumulative dose of immunosuppressive agents. We assessed renal flare of systemic lupus erythematosus, recurrence of lupus nephritis and graft failure as prognosis. The mean age of recipients with lupus nephritis was 43.5 years and all patients were female. Six patients had class III, 10 had class IV and three had class V. There were no meaningful differences in demographic data, renal replacement modality, cumulative doses of immunosuppressants and prognosis between recipients with and without lupus nephritis. Eight patients experienced renal flare of systemic lupus erythematosus, but there were no cases of recurrence of lupus nephritis or graft failure in recipients with lupus nephritis. Kidney-recipients with class IV lupus nephritis exhibited a lower cumulative renal flare of systemic lupus erythematosus free survival rate than those with class III lupus nephritis. In conclusion, renal outcome of kidney-transplantation in patients with lupus nephritis is similar to that in those without lupus nephritis, and class IV was associated with renal flare of systemic lupus erythematosus.


PLoS ONE ◽  
2019 ◽  
Vol 14 (2) ◽  
pp. e0212068 ◽  
Author(s):  
Ioannis Parodis ◽  
Huihua Ding ◽  
Agneta Zickert ◽  
Guillaume Cosson ◽  
Madiha Fathima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document